Compare WHWK & BMHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WHWK | BMHL |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.2M | 95.2M |
| IPO Year | N/A | 2025 |
| Metric | WHWK | BMHL |
|---|---|---|
| Price | $2.96 | $3.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 153.4K | 5.0K |
| Earning Date | 02-24-2026 | 01-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.50 |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $14,384,000.00 | $6,873,097.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $69.06 |
| Revenue Growth | N/A | ★ 66.02 |
| 52 Week Low | $1.39 | $2.72 |
| 52 Week High | $3.77 | $4.49 |
| Indicator | WHWK | BMHL |
|---|---|---|
| Relative Strength Index (RSI) | 64.66 | N/A |
| Support Level | $2.46 | N/A |
| Resistance Level | $2.77 | N/A |
| Average True Range (ATR) | 0.17 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 86.96 | 0.00 |
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.